Advanced search
Showing result 1 - 5 of 141 swedish dissertations matching the above criteria.
-
1. Hippocampal volumetry in mild cognitive impairment
Abstract : Dementia is a syndrome with cognitive decline as a prominent feature. MCI is similarly a syndrome of cognitive decline, albeit with much subtler symptoms, and has been identified as a condition at risk for progression to dementia. A considerable clinical challenge lies in identifying MCI patients with an underlying dementia disorder. READ MORE
-
2. Validation of brief cognitive tests in mild cognitive impairment, Alzheimer's disease and dementia with Lewy bodies
Abstract : Background It is estimated that 34 million people suffer from dementia, costing society US$422 billion each year. Alzheimer’s disease (AD) is the most common dementia and the global prevalence is predicted to increase to over 100 million people by the year 2050, with the greatest increase in developing countries. READ MORE
-
3. Prodromal Cognitive Signs of Dementia
Abstract : The increase in proportion of elderly worldwide, coupled with the fact that increasing age is a primary risk factor for dementia, have fuelled the efforts to unveil the warning signs of dementia. Although important achievements have been made in this field during the last decades, many questions are still to be answered. READ MORE
-
4. Cognitive impairment and its consequences in everyday life
Abstract : The overall aim was to improve knowledge of the consequences of cognitive dysfunction in everyday life and of instruments to make these assessments. The thesis contains four studies each of different design using different populations. READ MORE
-
5. The endocrine system in the progression of mild cognitive impairment to dementia
Abstract : Background and aims: Endocrine alterations have been related to cognitive decline, but the role of hormones may vary along the progression to manifest dementia. The overall aim of this thesis was to assess whether thyroid hormones (THs) and insulin-like growth factor-I (IGF-I) are dysregulated around the onset of Alzheimer’s disease (AD) and vascular dementia (VaD). READ MORE